Stay updated on Checkpoint Blockade in Relapsed Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the Checkpoint Blockade in Relapsed Mesothelioma Clinical Trial page.

Latest updates to the Checkpoint Blockade in Relapsed Mesothelioma Clinical Trial page
- Check6 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 on the ClinicalTrials.gov 403 error page.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe study page now displays a 403 Forbidden error page instead of the study details, with a minimal header/footer shown; the previously available study content and links appear to have been removed, indicating restricted access to the record.SummaryDifference19%

- Check48 days agoChange DetectedThe page adds an NIH grant/contract entry for 2016. It updates the page revision to v3.6.6, removing the previous v3.6.5 revision.SummaryDifference0.1%

- Check69 days agoChange DetectedRevision: v3.6.5 added. A large set of study documents, links, and institutional references (including consent forms, protocol, SAP, IPD sharing information, and the Southampton CTU) were removed from the page, reducing access to key governance and documentation.SummaryDifference17%

- Check83 days agoChange DetectedThe page’s revision label was updated from v3.6.3 to v3.6.4, indicating a small update to the page metadata.SummaryDifference0.0%

- Check105 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, indicating a small behind-the-scenes update to the page's software version.SummaryDifference0.0%

Stay in the know with updates to Checkpoint Blockade in Relapsed Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Checkpoint Blockade in Relapsed Mesothelioma Clinical Trial page.